The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine

Headache

Volumn 57, Issue , 2017, Pages 47-55

  Edvinsson, Lars ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

CGRP; CGRP receptor; CLR; gepants; monoclonal antibodies; RAMP1

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST;

ARTICLE; BRAIN CIRCULATION; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; COMPLEX FORMATION; CRANIAL NERVE; HUMAN; INNERVATION; MIGRAINE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRIGEMINOVASCULAR PATHWAY; TRIGEMINUS GANGLION; ANIMAL; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; HUMANS; MIGRAINE DISORDERS; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; TRIGEMINAL GANGLION;

EID: 85019163118     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.13081     Document Type: Article

References (46)

1. Goadsby PJ, Holland PR, Martins-Oliveira M, et al. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev. 2017;97:553-622.
2. Edvinsson L. Functional role of perivascular peptides in the control of cerebral circulation. Trends Neurosci. 1985;8:126-131.
3. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28:183-187.
4. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993;33:48-56.
5. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain. 1994;117:427-434.
6. Edvinsson L, Linde M. New drugs in migraine treatment and prophylaxis: Telcagepant and topiramate. Lancet. 2010;376:645-655.
7. Diener HC, Charles A, Goadsby PJ, Holle D. New therapeutic approaches for the prevention and treatment of migraine. Lancet Neurol. 2015;14:1010-1022.
8. Maniyar FA, Sprenger T, Monteith T, Schankin C, Goadsby PJ. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2014;137:232-241.
9. Schulte LH, May A. The migraine generator revisited: Continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016;139:1987-1993.
10. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995;1:658-660.
11. Eccles JC, Fatt P, Koketsu K. Cholinergic and inhibitory synapses in a pathway from motor-axon collaterals to motor neurons. J Physiol. 1954;126:524-562.
12. Nielsen KC, Owman C. Adrenergic innervation of pial arteries related to the circle of Willis in the cat. Brain Res. 1967;6:773-776.
13. Edvinsson L, Nielsen KC, Owman C, Sporrong B. Cholinergic mechanisms in pial vessels. Histochemistry, electron microscopy and pharmacology. Z Zellforsch Mikrosk Anat. 1972;134:311-325.
14. Edvinsson L, MacKenzie ET. Amine mechanisms in the cerebral circulation. Pharmacol Rev. 1976;28:275-348.
15. Burnstock G. Purinergic nerves. Pharmacol Rev. 1972;24:509-558.
16. Larsson LI, Edvinsson L, Fahrenkrug J, et al. Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves. Brain Res. 1976;11:400-404.
17. Edvinsson L, Fahrenkrug J, Hanko J, et al. VIP (vasoactive intestinal polypeptide)-containing nerves of intracranial arteries in mammals. Cell Tissue Res. 1980;208:135-142.
18. Lundberg JM, Hökfelt T. Multiple co-existence of peptides and classical transmitters in peripheral autonomic and sensory neurons—Functional and pharmacological implications. Prog Brain Res. 1986;68:241-262.
19. Edvinsson L, Uddman R. Neurobiology in primary headaches. Brain Res Brain Res Rev. 2005;48:438-456.
20. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 1982;298:240-244.
21. Rosenfeld MG, Mermod JJ, Amara SG, et al. Production of a novel neuropeptide encoded by the calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature. 1983;304:129-135.
22. Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: Trigeminal origin and coexistence with substance P. Neurosci Lett. 1985;62:131-136.
23. Walker CS, Hay DL. CGRP in the trigeminovascular system: A role for CGRP, adrenomedullin and amylin receptors? Br J Pharmacol. 2013;170:1293-1307.
24. Pietrobon D, Moskowitz MA. Pathophysiology of migraine. Annu Rev Physiol. 2013;75:365-391.
25. Diener HC. RPR100893 Study Group. RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. Cephalalgia. 2003;23:183-185.
26. Lennerz JK, Ruhle V, Ceppa EP, et al. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: Differences between peripheral and central CGRP receptor distribution. J Comp Neurol. 2008;507:1277-1299.
27. Eftekhari S, Salvatore CA, Calamari A, et al. Differential distribution of calcitonin gene-related peptide (CGRP) and its receptor components in the human trigeminal ganglion. Neuroscience. 2010;169:683-696.
28. Eftekhari S, Edvinsson L. Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and the spinal cord at C1-level. BMC Neuroscience. 2011;12:112.
29. Walker CS, Eftekhari S, Bower RL, et al. A second trigeminal CGRP receptor: Function and expression of the AMY1 receptor. Ann Clin Transl Neurol. 2015;2:595-608.
30. Edvinsson L, Fredholm BB, Hamel E, Jansen I, Verrecchia C. Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett. 1985;58:213-217.
31. Edvinsson L, McCulloch J, Kingman T, Uddman R, On the functional role of the trigeminocerebrovascular system in the regulation of cerebral circulation. In: Owman C, Hardebo JE, eds. Neural Regulation of the Cerebral Circulation. Amsterdam: Elsevier Science; 1986:407-418.
32. McCulloch J, Uddman R, Kingman TA, Edvinsson L. Calcitonin gene-related peptide: Functional role in cerebrovascular regulation. Proc Natl Acad Sci USA. 1986; 83:5731-5735.
33. Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol. 1988;23:193-196.
34. Ho TW, Edvinsson L, Goadsby PJ. CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol. 2010; 6:573-582.
35. Edvinsson L, Ekman R, Goadsby PJ. Measurement of vasoactive neuropeptides in biological materials: Problems and pitfalls from 30 years of experience and novel future approaches. Cephalalgia. 2010;30:761-766.
36. Cernuda-Morollón E, Larrosa D, Ramón C, et al. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology. 2013;81:1191-1196.
37. Hansen JM, Hauge AW, Olesen J, Ashina M. Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia. 2010;30:1179-1186.
38. Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci. 2011;12:570-584.
39. Eftekhari S, Gaspar RC, Roberts R, et al. Localization of CGRP receptor components and receptor binding sites in rhesus monkey brainstem: A detailed study using in situ hybridization, immunofluorescence, and autoradiography. J Comp Neurol. 2016;524:90-118.
40. Warfvinge K, Edvinsson L. Distribution of CGRP and CGRP receptor components in the rat brain. Cephalalgia. 2017;37.
41. Bower RL, Eftekhari S, Waldvogel HJ, et al. Mapping the calcitonin receptor in human brain stem. Am J Physiol Regul Integr Comp Physiol. 2016;310:R788-793.
42. Doods H, Arndt K, Rudolf K, Just S. CGRP antagonists: Unraveling the role of CGRP in migraine. Trends Pharmacol Sci. 2007;28:580-587.
43. Edvinsson L. CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment. Br J Clin Pharmacol. 2015;80:193-199.
44. Eftekhari S, Salvatore CA, Johansson S, et al. Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier. Brain Res. 2015;1600:93-109.
45. Hostetler ED, Joshi AD, Sanabria-Bohorquez S, et al. In vivo quantification of calcitonin gene-related peptide (CGRP) receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography (PET) tracer [11C]MK-4232. J Pharmacol Exp Ther. 2013;347:478-486.
46. Lundblad C, Haanes KA, Grände G, Edvinsson L. Experimental inflammation following dural application of complete Freund's adjuvant or inflammatory soup does not alter brain or trigeminal mircrovascular passage. J Headache Pain. 2015;16:91.